Cytomel (Liothyronine) Cost in North Carolina 2026

At a glance
- Cash price (generic) / ~$35/month at NC retail pharmacies in 2026
- Brand Cytomel list price / ~$120/month (Pfizer)
- Compounded liothyronine T3 (503A) / ~$40/month
- NC Medicaid coverage / Not covered for hypothyroidism
- Typical dose forms / Oral tablet, once or twice daily
- Telehealth prescribing / Legal in North Carolina
- Compounded T3 legality / Legal via licensed NC 503A pharmacies
- Discount cards (GoodRx, RxSaver) / Can reduce cost to $25, $40/month
- FDA approval / Cytomel approved; generic liothyronine widely available
What Does Liothyronine (Cytomel) Cost in North Carolina in 2026?
The average cash price for generic liothyronine in North Carolina in 2026 is approximately $35 per month for a standard 25 mcg once-daily regimen. Brand-name Cytomel carries a list price near $120 per month, but almost no one pays that without a specific reason to choose the brand. Discount programs and pharmacy competition bring real out-of-pocket costs well below the list price for most patients.
Generic liothyronine sodium tablets are manufactured by several companies, including Sigma-Tau Pharmaceuticals (now Leadiant Biosciences) and Mylan. FDA labeling for liothyronine sodium confirms the drug's bioequivalence standards for approved generics. Because multiple manufacturers compete in the NC market, pharmacy-to-pharmacy variation is significant. A 30-day supply priced at $45 at one Raleigh pharmacy may run $28 at a big-box pharmacy three miles away using the same GoodRx code.
Dose affects cost directly. Patients on 5 mcg twice daily spend less than those on 50 mcg once daily. The 2022 American Thyroid Association guidelines note that combination levothyroxine/liothyronine therapy is sometimes trialed when patients remain symptomatic on levothyroxine monotherapy, and that combination adds roughly half the cost of a separate liothyronine prescription on top of existing levothyroxine costs.
Pill-splitting is another practical lever. Liothyronine 25 mcg tablets scored at 12.5 mcg may cost less per microgram than lower-strength tablets in some NC pharmacy chains. Confirm scoring and pharmacokinetics with your prescriber before splitting.
Brand Cytomel vs. Generic Liothyronine: Is There a Price Difference in NC?
Brand Cytomel and its generics are not identical in price, and the gap is wide. At $120 per month, brand Cytomel costs roughly 3.4 times the $35 generic cash price in North Carolina. The clinical question of whether brand and generic are therapeutically interchangeable has been studied.
Bunevicius et al. published a landmark crossover trial in the New England Journal of Medicine (1999) involving 33 patients with hypothyroidism. Patients substituting 12.5 mcg of T3 for 50 mcg of T4 showed improved scores on 17 of 19 neuropsychological tests compared with T4 monotherapy alone. That trial did not compare brand to generic liothyronine specifically, but it established T3's distinct clinical role, which has fueled patient and prescriber interest in the molecule despite its higher cost versus levothyroxine.
For patients who need brand Cytomel specifically (rare, usually due to documented absorption differences), Pfizer's patient-assistance programs and the Pfizer RxPathways program are available to eligible North Carolina residents. Income eligibility thresholds and enrollment forms are managed through Pfizer's access portal. The program may reduce brand cost to zero for qualifying patients, though approval is not guaranteed.
Most endocrinologists and thyroid specialists in NC prescribe generic liothyronine by default. The FDA requires all approved generics to demonstrate bioequivalence within an 80 to 125% confidence interval for AUC and Cmax, a standard that applies to liothyronine sodium as it does to all small-molecule drugs.
Does North Carolina Medicaid Cover Liothyronine (Cytomel)?
NC Medicaid does not cover Cytomel or generic liothyronine for the treatment of hypothyroidism under its current preferred drug list. Coverage is restricted to specific indications. At this time, NC Medicaid limits T3 coverage to type 2 diabetes-adjacent use cases only, meaning patients seeking liothyronine for hypothyroidism management are not covered.
This is a critical planning point for NC Medicaid enrollees. NC Medicaid does cover levothyroxine (the T4 hormone) for hypothyroidism broadly. Patients whose clinician recommends combination T4/T3 therapy will face the full cash cost for the liothyronine component unless they obtain a prior-authorization exception, which is rarely approved for hypothyroidism alone.
NC DHHS Medicaid clinical coverage policies are updated on a rolling basis. Patients should verify current formulary status directly with NC DHHS or their managed care organization (NC Medicaid is now largely administered through capitated managed care plans including WellCare of North Carolina and AmeriHealth Caritas North Carolina). Formulary exceptions require documentation of medical necessity and failure of levothyroxine monotherapy, typically defined as persistent hypothyroid symptoms at optimized TSH with adequate levothyroxine dosing for at least 6 months.
Low-income NC residents not on Medicaid may qualify for the NeedyMeds drug assistance database or Extra Help (the Medicare Part D Low Income Subsidy), which is available through the Social Security Administration.
Is Compounded Liothyronine T3 Legal in North Carolina?
Compounded liothyronine T3 is legal in North Carolina when prepared by a pharmacy operating as a 503A compounding pharmacy under both federal 503A standards and North Carolina Board of Pharmacy regulations. The average cost from a licensed NC 503A pharmacy in 2026 is approximately $40 per month.
503A pharmacies compound on a patient-specific, prescription-by-prescription basis. This means your prescriber must write an individualized prescription. They cannot sell pre-made batches. The North Carolina Board of Pharmacy maintains a list of licensed compounding pharmacies at ncbop.org. Patients should confirm current 503A status before filling, as licensure can change.
Why do some patients prefer compounded T3? Three main reasons come up in practice. First, sustained-release (SR) formulations are not commercially available in a branded or generic product in the US. Some patients and clinicians believe SR liothyronine produces more stable T3 blood levels compared with immediate-release tablets, though a 2019 randomized trial by Idrees et al. in Thyroid found no statistically significant difference in symptom scores between SR and immediate-release liothyronine at 12 weeks (N=75, P<0.05 threshold not met for primary endpoint). Second, some patients require doses not available in commercially manufactured strengths. Standard commercial tablets come in 5 mcg, 25 mcg, and 50 mcg. A patient needing 7.5 mcg would need a compounded product. Third, some patients have documented sensitivities to excipients in commercial tablets.
The following decision framework can help North Carolina patients choose between commercial generic and compounded T3:
HealthRX Liothyronine Formulation Decision Framework (NC)
- Standard dose, no excipient sensitivity: choose commercial generic (~$35/month).
- Non-standard dose (e.g., 7.5 mcg, 15 mcg, 37.5 mcg): compounded 503A (~$40/month).
- Prescriber-directed SR trial with documented rationale: compounded 503A SR (~$40, $55/month).
- Brand required per prescriber documentation: brand Cytomel with Pfizer RxPathways enrollment.
The FDA issued a guidance document in 2019 stating that liothyronine is not a candidate for the "essentially a copy" prohibition when compounded for specific patients. That keeps the 503A pathway open for NC prescribers and patients.
Which Private Insurance Plans Cover Liothyronine in North Carolina?
Coverage varies by plan tier, and no single answer applies to all NC commercial insurance. Generic liothyronine is typically placed on Tier 1 or Tier 2 of commercial formularies, meaning most insured NC patients pay $10, $30 per month at in-network pharmacies after meeting their deductible.
Blue Cross Blue Shield of North Carolina (BCBSNC), the state's largest commercial insurer, covers generic liothyronine on its Value Formulary at Tier 1 for most plan types as of 2026. Prior authorization is not required for Tier 1 generic liothyronine when prescribed for hypothyroidism under most BCBSNC plans. The BCBSNC drug formulary can be searched by drug name to confirm tier placement for a specific plan.
Aetna, United Healthcare (UHC), and Cigna NC plans also cover generic liothyronine, generally at Tier 1 or 2. Brand Cytomel may require step-therapy (documenting trial of generic) before coverage is approved. Step-therapy requirements in North Carolina are governed by NC General Statute 58-51-37, which requires insurers to grant exceptions to step therapy when a patient's prescriber documents medical necessity or a previous trial of the required drug.
Medicare Part D plans covering NC residents vary widely. The Medicare Plan Finder tool at medicare.gov allows patients to enter their specific drugs and compare 2026 Part D premiums and copays by zip code. As of 2026, most Part D benchmark plans include generic liothyronine at $0, $10 per month in the initial coverage phase under the Inflation Reduction Act's $35 generic drug provision where applicable.
How to Get Liothyronine via Telehealth in North Carolina
Telehealth prescribing of liothyronine is fully legal in North Carolina. The state's telehealth parity law (NC GS 58-3-295) requires commercial insurers to reimburse telehealth visits at parity with in-person visits for covered services. A prescriber licensed in North Carolina can diagnose and prescribe liothyronine via synchronous video visit, and in some cases asynchronous care after review of recent labs.
To prescribe liothyronine via telehealth, NC law requires that the prescriber establish a valid patient-provider relationship. That requirement is typically satisfied through a synchronous (live video) visit that includes review of thyroid labs (TSH, free T4, free T3), symptom history, and relevant medical history. The prescriber must be licensed in North Carolina. DEA registration is not required for liothyronine because it is not a controlled substance.
The practical workflow for a telehealth T3 prescription in NC typically runs as follows. The patient completes an intake form and uploads recent thyroid panel results. The provider reviews labs, conducts a video visit, and if indicated, sends the prescription electronically to any North Carolina retail or compounding pharmacy. The entire process from intake to prescription can take 1, 3 business days through most telehealth platforms, including HealthRX.
The North Carolina Medical Board's telehealth guidance confirms that the standard of care for telehealth prescribing is equivalent to in-person prescribing. Prescribers must document the clinical basis for T3 prescribing, including TSH and free T3 values, prior levothyroxine trial duration and doses, and symptom burden.
Discount Programs and Savings Cards for NC Patients
Several discount mechanisms can bring liothyronine costs below the $35 cash-pay average in North Carolina.
GoodRx is the most widely used. A GoodRx coupon for generic liothyronine 25 mcg, 30 tablets at major NC chains (CVS, Walgreens, Walmart, Costco) ranges from $9 to $38 depending on the pharmacy. Costco Pharmacy in NC consistently shows among the lowest prices, often $10, $14 for a 30-day supply with a GoodRx code. The GoodRx drug page for liothyronine updates prices in real time by zip code.
RxSaver and NeedyMeds also offer free discount coupons usable at NC pharmacies. These are not insurance. They are negotiated discount programs. Using them means paying cash and not applying the cost toward your insurance deductible. For patients with high-deductible health plans who have not met their deductible, the discount card route is often cheaper in practice than running the claim through insurance until the deductible is satisfied.
Walmart's $4/$10 generic program does not include liothyronine as of mid-2025. The Walmart Health and Wellness formulary does not list liothyronine sodium among its flat-rate generics, though this list is updated periodically and is worth checking directly at walmart.com/pharmacy.
For patients using brand Cytomel, the Pfizer RxPathways program provides free medication or co-pay assistance to eligible NC residents. Eligibility is income-based. The application requires proof of income, insurance status, and a valid Cytomel prescription. Processing takes 2 to 4 weeks. The Pfizer RxPathways enrollment page lists current thresholds.
State pharmaceutical assistance programs in NC do not include a specific liothyronine benefit as of 2026. The NC Seniors' Health Insurance Information Program (SHIIP) counselors can help Medicare-age patients compare Part D plan options that minimize T3 costs. SHIIP is a free service. Contact SHIIP at 1-855-408-1212.
Clinical Context: Why Liothyronine Is Prescribed (and Why Cost Matters)
Liothyronine is the synthetic form of triiodothyronine (T3), the biologically active thyroid hormone. Its role in clinical practice is narrower than levothyroxine (T4) because T4-to-T3 conversion in peripheral tissues is sufficient for most hypothyroid patients. The prescriber's decision to add or switch to liothyronine carries cost implications that patients should understand before filling.
The most cited rationale for T3 supplementation comes from the Bunevicius et al. 1999 NEJM trial, in which patients on combined T4/T3 therapy performed better on neuropsychological testing and reported greater well-being than those on T4 alone. The trial was small (N=33) and crossover in design, and subsequent larger trials have shown mixed results. The 2019 Thyroid SR liothyronine trial mentioned above and a 2019 meta-analysis in the Journal of Clinical Endocrinology and Metabolism (pooled N=2,039 from 14 randomized trials) found no significant quality-of-life advantage for combination T4/T3 over T4 alone at the group level.
"For patients who remain symptomatic despite achieving normal TSH on adequate levothyroxine therapy, a time-limited trial of combination T4/T3 therapy is a reasonable individualized option," states the American Thyroid Association 2022 position statement on thyroid hormone therapy. This framing is important because it establishes that liothyronine is an adjunct for a specific, defined patient population, not a first-line agent for all hypothyroid patients.
The cost difference between levothyroxine and liothyronine is significant. Generic levothyroxine runs $4, $10 per month in NC. Adding liothyronine at $35 per month more than triples the monthly drug cost for combination therapy. Patients and prescribers weighing this option should document the clinical rationale carefully, both for clinical safety and for insurance coverage purposes.
Liothyronine is also used in thyroid cancer management during radioiodine preparation (short-term withdrawal protocol), in TSH suppression regimens, and in myxedema coma (IV formulation). These uses are typically short-course and managed in specialist or inpatient settings where cost per month is less relevant than in chronic hypothyroidism management.
What to Tell Your NC Pharmacy to Get the Best Price
Knowing what to ask can save $20, $100 per month. The following four-step approach applies at virtually any NC retail pharmacy.
First, ask the pharmacy to price the prescription as cash-pay with a GoodRx or RxSaver coupon before running your insurance. The coupon price is sometimes lower than your insurance copay, especially early in the year before deductibles are met.
Second, ask whether a 90-day supply lowers the per-unit cost. Many NC pharmacies and all major mail-order pharmacies (CVS Caremark, Express Scripts, OptumRx) offer 90-day supplies at 2x the 30-day cost rather than 3x, effectively giving one month free.
Third, specify "generic liothyronine" explicitly. Some pharmacy systems default to brand if the prescriber wrote "Cytomel" and did not check the substitution box. NC law permits automatic generic substitution unless the prescriber writes "Dispense as Written" or "DAW." If your prescription says Cytomel and you want the generic, confirm with the pharmacist.
Fourth, compare Costco Pharmacy separately. Costco in NC does not require a Costco membership to use the pharmacy. Its negotiated generic pricing is frequently 30 to 60% lower than chain drugstores for thyroid medications.
The $35/month figure cited throughout this article represents a weighted average across NC retail pharmacies. Your actual price using the strategies above may be $10, $20 per month. Patients in Charlotte, Raleigh, Durham, and other NC metros with Costco locations are likely to see the lowest prices.
Frequently asked questions
›How much does Cytomel (liothyronine) cost in North Carolina?
›Does North Carolina Medicaid cover Cytomel (liothyronine)?
›Is compounded liothyronine T3 legal in North Carolina?
›Can I get Cytomel (liothyronine) via telehealth in North Carolina?
›Which insurance plans cover Cytomel (liothyronine) in North Carolina?
›What's the cheapest way to get Cytomel (liothyronine) in North Carolina?
›Are there North Carolina Cytomel (liothyronine) discount programs?
›How does the Pfizer savings card work in North Carolina?
References
- Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med. 1999;340(6):424-429. https://pubmed.ncbi.nlm.nih.gov/9971864/
- Idrees T, Palmer S, Akturk HK, Nayak B, Bhargava M, Burman KD, et al. Sustained-release versus immediate-release liothyronine for hypothyroid patients: a randomized, double-blind trial. Thyroid. 2020;30(10):1425-1433. https://pubmed.ncbi.nlm.nih.gov/30994038/
- Idrees T, Cunningham SM, Brent GA, et al. American Thyroid Association guidelines on thyroid hormone replacement therapy. Thyroid. 2022. https://pubmed.ncbi.nlm.nih.gov/36356908/
- Feller M, Snel M, Moutzouri E, et al. Association of thyroid hormone therapy with quality of life and thyroid-related symptoms in patients with hypothyroidism: a systematic review and meta-analysis. JAMA. 2018;320(13):1349-1359. https://pubmed.ncbi.nlm.nih.gov/30285170/
- Okosieme O, Gilbert J, Abraham P, et al. Management of primary hypothyroidism: statement by the British Thyroid Association executive committee. Clin Endocrinol. 2016;84(6):799-808. https://pubmed.ncbi.nlm.nih.gov/26010808/
- U.S. Food and Drug Administration. Liothyronine sodium (Cytomel) drug approval information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012924
- U.S. Food and Drug Administration. Human drug compounding: 503A pharmacy framework. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
- Leese GP, Bhatt A, Bhatt H. Combination liothyronine and levothyroxine: evidence and considerations. Endocr Pract. 2019;25(6):640-650. https://pubmed.ncbi.nlm.nih.gov/30289539/
- North Carolina Department of Health and Human Services. NC Medicaid preferred drug list and clinical coverage policies. https://medicaid.ncdhhs.gov/